NCT07619612

Brief Summary

Obesity is associated with impaired vascular function, metabolic dysfunction, and reduced physical fitness, which increase cardiovascular disease risk. This randomized controlled trial aims to investigate the effects of a 12-week home-based circuit training program using light-to-moderate resistance on vascular health, body composition, metabolic function, resting metabolic rate, substrate oxidation, physical activity, and physical fitness in adults with obesity. Participants will be randomly assigned to either a home-based circuit training group or a control group maintaining usual daily activities. The findings may support the use of home-based exercise as a practical and time-efficient strategy for obesity management and cardiovascular risk reduction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 18, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

May 26, 2026

Last Update Submit

May 26, 2026

Conditions

Keywords

: circuit training, vascular function, cardiometabolic, physical fitness, obesity

Outcome Measures

Primary Outcomes (1)

  • Vascular Function

    Change in flow-mediated dilation from baseline to 12 weeks.

    Baseline and 12 weeks

Study Arms (2)

Home-Based Circuit Training

EXPERIMENTAL

Participants in this group will perform a 12-week home-based circuit training program three times per week. Each session includes warm-up, circuit exercise, and cool-down components designed to improve vascular and metabolic health.

Behavioral: Home-Based Circuit Training

Control Group

NO INTERVENTION

participants in the control group will maintain their usual daily activities without participating in the exercise intervention during the study period.

Interventions

Participants will perform a 12-week home-based circuit training program three times per week. Each session includes warm-up, circuit-based exercises targeting major muscle groups, and cool-down activities. The intervention is designed to improve vascular and metabolic health in adults with obesity. The training program consisted of two phases: phase 1 (weeks 1-6) and phase 2 (weeks 7-12). During phase 1, participants performed resistance exercises at an intensity of 65-70% of one-repetition maximum (1RM). Each exercise consisted of 12 repetitions, with a 1-minute rest between exercises. The lifting tempo was maintained at 2:2 (concentric: eccentric). Participants completed 8 exercises per circuit for a total of 3 circuits, with a 2-minute rest between circuits. During phase 2, the intensity was increased to 70-75% of 1RM, while maintaining 12 repetitions per exercise. The rest interval between exercises was reduced to 30 seconds, with the same lifting tempo (2:2). Participants complete

Home-Based Circuit Training

Eligibility Criteria

Age19 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults with obesity according to the Asia-Pacific criteria (body mass index \[BMI\] ≥ 27.5 kg/m²).
  • Able to participate in a home-based exercise program.
  • Willing to provide written informed consent.

You may not qualify if:

  • History of uncontrolled diabetes (HbA1c ≥ 10% or blood glucose ≥ 200 mg/dL).
  • Uncontrolled hypertension (≥ 140/90 mmHg).
  • Cardiovascular disease.
  • Chronic obstructive pulmonary disease.
  • Orthopedic conditions limiting exercise participation.
  • Participation in regular exercise programs or sports activities within the previous 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Sports Science, Chulalongkorn University

Bangkok, ฺBangkok, 10330, Thailand

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Daroonwan Suksom, PhD

    Faculty of Sports Science, Chulalongkorn University, Bangkok, Thailand

    STUDY DIRECTOR
  • Tunyakarn Worasettawat, PhD

    Faculty of Sports Science, Chulalongkorn University, Bangkok, Thailand

    PRINCIPAL INVESTIGATOR
  • Hirofumi Tanaka, PhD

    Department of Kinesiology and Health Education, The University of Texas at Austin, USA

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either a home-based circuit training group or a control group in a parallel-group design.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 2, 2026

Study Start

June 18, 2025

Primary Completion

August 31, 2025

Study Completion

December 25, 2025

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) may be shared upon reasonable request after publication of the study results and approval by the principal investigator.

Locations